Applied Materials: The Next Correction Candidate

Applied Materials (AMAT) is rated Hold as its revenue and earnings growth continue to lag peers such as LRCX, ASML, and KLAC, despite recent stock outperformance. Gross margin expansion and Q2 2026 guidance calling for 7% YoY and 9% QoQ revenue growth are positives, but the article argues much of that upside is already priced into the valuation.

Analysis

AMAT’s issue is not that the cycle is weak; it’s that the market is paying a cyclical multiple for a company still behaving like a laggard in a strong semi-capex tape. When peers with cleaner exposure to high-value process steps or stronger installed-base leverage are compounding faster, incremental upside tends to be captured by the names with more operating leverage and less execution drag. That usually shows up first in valuation dispersion before it shows up in revisions, so the market can keep rewarding AMAT near term even while relative fundamentals deteriorate.

The second-order risk is that margin progress can mask mix weakness. If revenue growth is being defended by richer systems/service mix or pricing discipline rather than true demand share gains, the earnings inflection is less durable than headline guidance implies. In that setup, any slowdown in leading-edge WFE or a pause in memory upgrades would hit AMAT harder than LRCX or ASML because the market is already assuming the improvement is self-sustaining.

Catalyst-wise, the next 1-2 quarters matter more than the next 12 months: if guidance beats but order commentary stays cautious, the stock can de-rate even on good prints. Conversely, a clear reacceleration in bookings or evidence that margin expansion is converting into faster EPS growth would force a rerating, but that needs proof, not narrative. The contrarian point is that relative underperformance among semi-equipment names can create a crowded “best-quality only” trade; if AMAT’s execution merely normalizes, the stock can grind higher even without becoming a leader.

The cleanest setup is to use AMAT strength to express a relative-value short versus a better-quality peer basket, rather than a naked short. The upside in AMAT from here looks capped unless estimates move materially, while the downside is sharper if the market realizes the current guide already embeds a lot of the recovery. That makes this a better calendar trade than a thesis short: you want to own the next catalyst window, not the entire cycle.

Key Decisions for Investors

• Short AMAT / long LRCX as a 3-6 month relative-value pair; target 10-15% outperformance of the long leg if semi-capex breadth remains selective. Best entry is on any post-print squeeze in AMAT or peer sympathy rally.
• If you need directional exposure to semicap upside, prefer ASML or LRCX over AMAT for the next 2 quarters; they offer cleaner operating leverage and should outperform if WFE revisions continue.
• Sell upside on AMAT via 1-2 month call spreads into strength; the risk/reward favors premium harvesting because near-term guidance improvement appears more than reflected in the current tape.